Peru Says Sinopharm May Resume Coronavirus Vaccine Trial After Volunteer’s Illness

Peru’s government said on Tuesday negotiations with Sinopharm to purchase COVID-19 vaccines are “well advanced.”

RIO DE JANEIRO, BRAZIL - (Reuters) The Peruvian health minister said on Wednesday, December 16th, that China’s Sinopharm could resume a trial for its coronavirus vaccine in the hard-hit Andean nation, just days after authorities suspended the tests to better understand why a volunteer had fallen ill.

Health authorities announced over the weekend that the Sinopharm trial would be temporarily halted as a safety measure after a volunteer experienced decreased strength in his legs, among other symptoms.

“We have had several meetings with Sinopharm and ... the suspension has been lifted today (Wednesday),” Health Minister Pilar Mazzetti said.

Sinopharm Group . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?